1. Best practices for communication between IND sponsors and FDA during drug development: guidance for industry and review staff : good review practice Publication: Silver Spring, MD : Center for Drug Evaluation and Research, December 2017 Subject(s): CommunicationDrug IndustryInvestigational New Drug ApplicationHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
